Sundrug Statistics

Total Valuation

Sundrug has a market cap or net worth of JPY 563.78 billion. The enterprise value is 545.02 billion.

Market Cap	563.78B
Enterprise Value	545.02B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Sundrug has 116.97 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	116.97M
Shares Outstanding	116.97M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	4.61%
Owned by Institutions (%)	25.58%
Float	67.03M

Valuation Ratios

The trailing PE ratio is 17.95 and the forward PE ratio is 16.91. Sundrug's PEG ratio is 2.88.

PE Ratio	17.95
Forward PE	16.91
PS Ratio	0.69
PB Ratio	2.09
P/TBV Ratio	2.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.88

Financial Ratio History

Enterprise Valuation

EV / Earnings	17.36
EV / Sales	0.67
EV / EBITDA	8.74
EV / EBIT	12.24
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.16.

Current Ratio	1.76
Quick Ratio	0.75
Debt / Equity	0.16
Debt / EBITDA	0.69
Debt / FCF	n/a
Interest Coverage	204.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	14.31%
Revenue Per Employee	114.06M
Profits Per Employee	4.40M
Employee Count	7,145
Asset Turnover	1.90
Inventory Turnover	6.18

Taxes

In the past 12 months, Sundrug has paid 13.68 billion in taxes.

Income Tax	13.68B
Effective Tax Rate	30.34%

Stock Price Statistics

The stock price has increased by +24.20% in the last 52 weeks. The beta is 0.22, so Sundrug's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	+24.20%
50-Day Moving Average	4,516.40
200-Day Moving Average	4,245.20
Relative Strength Index (RSI)	64.06
Average Volume (20 Days)	344,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sundrug had revenue of JPY 814.94 billion and earned 31.40 billion in profits. Earnings per share was 268.49.

Revenue	814.94B
Gross Profit	208.27B
Operating Income	45.86B
Pretax Income	45.08B
Net Income	31.40B
EBITDA	63.68B
EBIT	45.86B
Earnings Per Share (EPS)	268.49

Full Income Statement

Balance Sheet

The company has 62.98 billion in cash and 44.22 billion in debt, giving a net cash position of 18.77 billion or 160.43 per share.

Cash & Cash Equivalents	62.98B
Total Debt	44.22B
Net Cash	18.77B
Net Cash Per Share	160.43
Equity (Book Value)	270.06B
Book Value Per Share	2,308.88
Working Capital	93.11B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 25.56%, with operating and profit margins of 5.63% and 3.85%.

Gross Margin	25.56%
Operating Margin	5.63%
Pretax Margin	5.53%
Profit Margin	3.85%
EBITDA Margin	7.81%
EBIT Margin	5.63%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 131.00, which amounts to a dividend yield of 2.72%.

Dividend Per Share	131.00
Dividend Yield	2.72%
Dividend Growth (YoY)	6.56%
Years of Dividend Growth	6
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	2.84%
Earnings Yield	5.57%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.

Last Split Date	Mar 29, 2017
Split Type	Forward
Split Ratio	2

Scores

Sundrug has an Altman Z-Score of 4.97 and a Piotroski F-Score of 3.

Altman Z-Score	4.97
Piotroski F-Score	3